Abiomed
ABMD
#1109
Rank
โ‚ฌ16.40 B
Marketcap
363,72ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : โ‚ฌ0.14 Billion

According to Abiomed's latest financial reports the company's total liabilities are โ‚ฌ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31โ‚ฌ0.15 B8.47%
2021-03-31โ‚ฌ0.14 B2.62%
2020-03-31โ‚ฌ0.13 B30.9%
2019-03-31โ‚ฌ0.10 B33.14%
2018-03-31โ‚ฌ78.54 M-14.64%
2017-03-31โ‚ฌ92.02 M89.1%
2016-03-31โ‚ฌ48.66 M12.59%
2015-03-31โ‚ฌ43.21 M60.4%
2014-03-31โ‚ฌ26.94 M4.95%
2013-03-31โ‚ฌ25.67 M24.02%
2012-03-31โ‚ฌ20.7 M8.89%
2011-03-31โ‚ฌ19.01 M18.81%
2010-03-31โ‚ฌ16 M6.11%
2009-03-31โ‚ฌ15.07 M-2.77%
2008-03-31โ‚ฌ15.5 M46.84%
2007-03-31โ‚ฌ10.56 M41.39%
2006-03-31โ‚ฌ7.46 M98.39%
2005-03-31โ‚ฌ3.76 M-3.92%
2004-03-31โ‚ฌ3.91 M-32.09%
2003-03-31โ‚ฌ5.77 M-50.62%
2002-03-31โ‚ฌ11.68 M9.65%
2001-03-31โ‚ฌ10.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ2.86 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.34 B 10,822.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.14 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA